PFE vs V: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
Visa Inc. · Financial Services
$327.24
+27.8% upside to fair value
Grade A
High Quality
QuantHub Verdict
V has more upside to fair value
(+27.8%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
V |
| Current Price |
$25.22 |
$327.24 |
| Fair Value Estimate |
$25.92 |
$418.15 |
| Upside to Fair Value |
+2.8%
|
+27.8%
|
| Market Cap |
$143.7B |
$627.3B |
| Forward P/E |
19.2x
|
28.2x
|
| EV / EBITDA |
12.3x
|
22.6x
|
| Price / Sales |
2.3x
|
14.6x
|
| Price / FCF |
15.2x
|
29.6x
|
| Revenue Growth YoY |
+5.4%
|
+17.1%
|
| Gross Margin |
69.3%
|
81.3%
|
| Operating Margin |
23.4%
|
61.1%
|
| Return on Equity |
8.4%
|
58.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.6%
|
3.38%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Visa Inc. operates a global payments network that facilitates electronic funds transfers worldwide, primarily through credit and debit cards. The company benefits from a very strong and widening moat driven by its extensive global card network and acceptance infrastructure, supported by a shareholder-friendly capital allocation policy including high buybacks and dividends. Visa's business quality…
Accumulation Zones
| Metric |
PFE |
V |
| Zone Low |
$19.44 |
$313.61 |
| Zone High |
$22.03 |
$355.43 |
| In Buy Zone? |
No
|
Yes
|